Healthstream (HSTM) FY2016 results: revenue $192 million, down 8.1% on the year
Healthstream Inc. (HSTM) reported revenue of $192 million for fiscal 2016, the year ended 31 December 2016, down 8.1% on the year before. Net income was $4 million, down 56.4%, and diluted earnings per share $0.12. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2019.
Revenue
$192 million
-8.1% on the year
FY2009FY2016
Operating margin
3.7%
6.5% a year earlier
FY2009FY2016
Net income
$4 million
-56.4% on the year
FY2009FY2016
Diluted EPS
$0.12
-57.1% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
192
209
171
-8.1%
Research and development
24.2
24.2
16.5
+0.1%
Operating income
7.2
13.6
16.4
-47.1%
Operating margin
3.7%
6.5%
9.6%
Pre-tax income
7.8
13.7
16.5
-43.5%
Income tax
3.0
5.1
6.1
-41.9%
Effective tax rate
38.2%
37.2%
37.1%
Net income
3.8
8.6
10.4
-56.4%
Net margin
2.0%
4.1%
6.1%
Diluted EPS
$0.12
$0.28
$0.37
-57.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
24.2
34.9
34.3
-30.6%
Capital expenditure
4.8
8.1
4.5
-40.6%
Free cash flow
19.4
26.8
29.7
-27.6%
Free cash flow margin
10.1%
12.8%
17.4%
Cash from investing
-56.7
n/a
n/a
Cash from financing
0.0
n/a
n/a
Depreciation and amortisation
20.4
17.0
10.9
+19.8%
Share-based compensation
1.9
3.3
1.6
-42.2%
Diluted shares, weighted
32m
30m
28m
+5.4%
Shares outstanding at period end
32m
32m
28m
+0.3%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
286
280
168
+2.1%
Debt
0.0
0.0
0.0
Other liabilities
110
99.2
89.4
+10.7%
Total liabilities and equity
396
380
257
+4.3%
Fixed assets
10.2
12.5
9.4
-17.8%
Goodwill
85.6
83.1
41.9
+3.1%
Intangible assets
78.4
56.0
14.8
+40.0%
Investments
53.5
67.0
39.0
-20.1%
Cash and equivalents
49.6
82.0
82.0
-39.5%
Receivables
44.8
36.3
33.2
+23.3%
Other assets
73.8
42.7
37.0
+72.7%
Total assets
396
380
257
+4.3%
10-K for the year ended 31 December 2016, filed 25 February 2019: the filing.